Search by Drug Name or NDC
NDC 64253-0900-91 Calcium Chloride 100 mg/mL Details
Calcium Chloride 100 mg/mL
Calcium Chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medefil, Inc.. The primary component is CALCIUM CHLORIDE.
Product Information
| NDC | 64253-0900 |
|---|---|
| Product ID | 64253-900_fd8f5c27-f125-4390-e053-6394a90a39c4 |
| Associated GPIs | 79100010002010 |
| GCN Sequence Number | 001349 |
| GCN Sequence Number Description | calcium chloride SYRINGE 100 MG/ML INTRAVEN |
| HIC3 | C1F |
| HIC3 Description | CALCIUM REPLACEMENT |
| GCN | 03751 |
| HICL Sequence Number | 000582 |
| HICL Sequence Number Description | CALCIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Calcium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calcium Chloride Injection |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | CALCIUM CHLORIDE |
| Labeler Name | Medefil, Inc. |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211553 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64253-0900-91 (64253090091)
| NDC Package Code | 64253-900-91 |
|---|---|
| Billing NDC | 64253090091 |
| Package | 10 SYRINGE, PLASTIC in 1 BOX (64253-900-91) / 10 mL in 1 SYRINGE, PLASTIC |
| Marketing Start Date | 2020-09-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |